Esketamine for Major Depressive Disorder User Reviews (Page 3)
Brand names: Spravato
Esketamine has an average rating of 6.9 out of 10 from a total of 52 reviews for the treatment of Major Depressive Disorder. 58% of reviewers reported a positive experience, while 23% reported a negative experience.
Reviews for Esketamine
- Shakes
- Taken for 1 to 6 months
- March 13, 2024
Spravato (esketamine) "I have had a very positive experience so far. It's been a rough road, but I now have some hope. I pray that this treatment will be the end of the nightmare of MDD."
- Fly...
- Taken for 1 to 6 months
- February 1, 2023
Spravato (esketamine) "I have had 15 treatments and have not gotten any better. Don't know if it's worth continuing treatments, speaking with my DR today. 25+ years of Treatment Resistant depression, nothing yet."
Frequently asked questions
- TheSc...
- Taken for 6 months to 1 year
- July 24, 2022
Spravato (esketamine) "It worked, but it was short term relief. I had to discontinue due to getting migraine headaches that got worse"
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Major Depressive Disorder
Care guides
More about esketamine
- Check interactions
- Compare alternatives
- Reviews (129)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antidepressants
- Breastfeeding
- En español
Spravato (esketamine) "My first time was yesterday and it was not a good experience. I want to ask if the 2nd time may be better?"